← Back
Analysis Case Study · 01 Published May 2026

Medi-Aesthetic Sales Insights, UK & Ireland

An AI pipeline that filtered 1M+ Kaia transcript rows down to 98 verified UK & Irish medi-aesthetic prospects, extracted structured insights per call, and synthesized two regional briefings plus an editorial dashboard, for ~$8 in API spend, in under ten minutes of runtime.

TL;DR

We built an AI-powered analysis pipeline that filters Phorest's Outreach Kaia call archive down to medi-aesthetic prospects in the UK and Republic of Ireland, uses Claude AI to classify each call by country and extract structured insights (current software, features wanted, issues, decision stage, regulatory signals), and synthesizes the results into two written sales-intelligence briefings plus a single-file interactive editorial dashboard. 98 verified transcripts processed end-to-end (filtered from 740 medi-aesthetic calls globally) for ~$8 in API spend, runtime under 10 minutes.


The Problem

Phorest sales and leadership teams had no consolidated, country-segmented view of what UK and Irish medi-aesthetic clinics actually want, who they're switching from, or what's blocking their deals. Hundreds of demo recordings sit in Kaia full of competitive intelligence, but nobody has time to listen to them all.


The Solution: Five-Stage Pipeline

Stage 1, Filter

Regex pass over the 224 MB Kaia CSV. Strong signals (medi-aesthetic, med spa, injectable, botox, dermal filler) and weak signals (multiple procedure terms + medical context).

Output: medi-aesthetic-transcripts.csv, 740 transcripts globally with title, date, duration, participants, matched terms, match strength.

Stage 2, Country Classification (Claude Haiku 4.5)

For each of the 740 transcripts, sends the title plus the first 4,000 characters to Claude Haiku 4.5 with a strict classification prompt. Returns JSON: {country, confidence, evidence}.

Ignore rep accent and rep nationality. Only customer-side evidence counts, customer-stated city, currency (£ / € / $), regulators (NHS, CQC, JCCP, NMC, HPRA, HSE), customer-side .co.uk / .ie domains.

12 parallel API calls; a recovery pass re-runs "unknown" classifications with 12,000 characters of context, recovering 23 more genuine UK/IE matches. Total cost: ~$0.10.

Stage 3, Insight Extraction (Claude Sonnet 4.6)

For each UK/IE candidate, sends the full transcript (up to 80,000 characters) to Claude Sonnet 4.6. The schema captures verified country, business name and type, clinic size, channel, current software, issues, features wanted, medi-aesthetic specifics, decision stage, objections, and notable quotes.

The verification field caught false positives the Haiku classifier missed, of 24 "presumed IE" classifications, only 11 verified as actually Irish customer-side. Final verified counts: 87 UK · 11 IE.

Stage 4, Synthesis (Claude Sonnet 4.6)

Aggregates the structured per-transcript JSON into per-region counts and sends aggregates + per-row metadata to Sonnet with an analyst-briefing prompt. Output: two long-form Markdown reports, UK (21 KB) and IE (15 KB), written to be decision-ready for sales leadership, not generic "5 takeaways" content.

Stage 5, Editorial Dashboard

Single-file HTML dashboard. No framework dependencies, custom CSS, Chart.js, Marked.js, all CDN-loaded. Editorial-quarterly aesthetic in Phorest brand colors: Fraunces serif display + Geist body + JetBrains Mono for data labels; deep teal-green and coral on cream paper; hairline rules; numbered sections (I–VII); Fig. references on charts (02.A, 02.B etc.).

Three tabs (UK · Ireland · Compare), headline metric strip, eight custom-themed charts per region, a searchable per-transcript roster with stage filters, and the full synthesized briefing rendered inline with editorial typography. Prints clean for board packs.


Results

BeforeAfter
No segmented view of UK/IE medi-aesthetic prospects98 verified transcripts, fully structured per region
"I think Pabau is our biggest competitor" (anecdote)Quantified: Pabau #1 in UK with 13 active defectors
Reps unaware of regulatory leverageJune 2025 GMC rules flagged as live sales lever; HSE prescriber/injector split surfaced for Ireland
No view of pipeline stage distribution13 ready-to-buy in UK, 3 in IE, named businesses, specific blockers
Hundreds of recordings unreadAll 98 distilled into a drillable dashboard + two briefings

Headline findings, UK (n = 87)

Headline findings, Ireland (n = 11)


What We Learned


Tech Stack